What is OptimizeRx's treasury stock?

OptimizeRx (OPRX) reported treasury stock of $2K in Q1 2026.

How has OptimizeRx's treasury stock changed year-over-year?

OptimizeRx's treasury stock decreased by 0.0% year-over-year, from $2K to $2K.

What is the long-term trend for OptimizeRx's treasury stock?

Over 3 years (2022 to 2025), OptimizeRx's treasury stock has grown at a 18.1% compound annual growth rate (CAGR), from $1.21K to $2K.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

OptimizeRx OPRX Treasury Stock

Treasury Stock at other companies

PhreesiaPHR

$46.62M+2.4%

PubMaticPUBM

$202.3M+34.5%

National Research CorporationNRC

$154.48M+12.8%

Fluent, Inc.FLNT

$11.41M0.0%

Quad GraphicsQUAD

$34.5M+9.9%

DoubleVerify HoldingsDV

$304.94M+40.7%

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's treasury stock?: OptimizeRx (OPRX) reported treasury stock of $2K in Q1 2026.
How has OptimizeRx's treasury stock changed year-over-year?: OptimizeRx's treasury stock decreased by 0.0% year-over-year, from $2K to $2K.
What is the long-term trend for OptimizeRx's treasury stock?: Over 3 years (2022 to 2025), OptimizeRx's treasury stock has grown at a 18.1% compound annual growth rate (CAGR), from $1.21K to $2K.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.